PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus  by Mounika, P. et al.
PHS7
PREVALENCE AND COST OF ILLNESS OF SPECIFIC CONDITIONS IN A
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OBJECTIVES: To calculate the prevalence rates and costs of common conditions
using medical and pharmacy claims from a commercially insured US population in
2010. METHODS: This retrospective cohort analysis used administrative claims
data from 14 major US health plans. Patients had 1 claim for a targeted condition
(identified by ICD-9 or GPI codes) from 01/01/2010 through 12/31/2010. Descriptive
statistics included means and relative frequencies. Costs reported for patients with
12 months continuous eligibility and presented as annualized per patient per
month (PMPM) costs to include all patients regardless of length of eligibility. Pa-
tients were required to have 1 day of eligibility. RESULTS: The 10 most prevalent
conditions: hyperlipidemia (13.9%), hypertension (13.6%), allergic rhinitis (5.6%),
diabetes (4.8%), COPD/COPD-associated conditions (4.8%), diabetes without com-
plications (4.7%), depression (other than major depression and bipolar disorder)
4.0%, osteoarthritis (3.8%), asthma (3.6%), osteoporosis/osteopenia (2.8%). Allergic
rhinitis was most common among those 34 yrs; hyperlipidemia among patients
aged 35-64 yrs; hypertension among patients 65 yrs. Highest average (PMPM)
medical costs were: bone cancer $82,173 ($119,528); CNS cancer $81,101 ($110,829);
brain cancer $74,055 ($187,244); subarachnoid hemorrhage $67,324 ($161,164); in-
tracerebral hemorrhage $60,968 ($203,551); multiple myeloma $43,495 ($68,614);
leukemia $41,873 ($68,703); lung cancer $40,691 ($97,279); colorectal cancer $34,498
($65,025). Highest average (PMPM) pharmacy costs were: multiple myeloma $17,567
($18,907); multiple sclerosis $14,198 ($14,682); leukemia $9,050 ($$9,983); psoriatic
arthritis $8,035 ($8,291); brain cancer $7,766 ($8,861); ankylosing spondylitis $5,989
($6,324); bone cancer $5,211 ($5,498); CNS cancer $4,697 ($5,748); renal cancer $4,620
($5,507). CONCLUSIONS: Hyperlipidemia and hypertension were more than twice
as prevalent as the next most prevalent condition in 2010; this pattern held for
males and females and generally held across geographic regions of the U.S. Con-
sistent with prior research, cancers and cancer treatments were consistently
ranked among the most expensive for health plans in 2010.
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OBJECTIVES: Foot complications (e.g. infections, abscesses) are common in pa-
tients with diabetes mellitus (DM) and are associated with high morbidity and risk
of lower extremity amputation. The objective of this analysis was to estimate the
incidence of foot complications in patients with a diabetes diagnosis. METHODS:
DM population in Lombardy Region (Italy) was identified through a data warehouse
(DENALI), matching with probabilistic record linkage demographic, clinical and
economic data of different Healthcare Administrative databases. We selected in-
dividuals with diabetes diagnosis prior to December 31, 2000 (hospital discharge
with an IDC-9 CM code 250.XX, and/or two consecutive prescriptions of drugs for
diabetes (ATC code A10XXXX) within one year, and/or an exemption from co-
payment health care costs specific for DM). From this cohort, we detected patients
requiring at least one hospitalization for toe and foot complications (e.g. ICD-9 CM
682.7, “Other cellulitis and abscess-Foot”) in the next 9 years of follow-up.
RESULTS: Over the follow-up period, 5,096 of the 1,322,686 hospitalizations of DM
patients (0.39%), were attributable to foot and toe complications. We individuated
3,404 patients (1.09% of the overall diabetes population; N312,223) with at least
one hospitalization for foot and toe complications (males: 64.72%, mean age: 64.64
years). The most frequent conditions were lower limb amputations (ICD-9 CM:
V497.X; N1,729 patients), cellulitis and abscesses of foot (ICD-9 CM: 682.7; N976
patients) and cellulitis and abscesses of toe (ICD-9 CM: 681.1; N783 patients).
Considering the overall observation period (831 million days, 7.29 years per pa-
tient), incidence rates were 0.76, 0.43 and 0.35 events per 1,000 pts-year, for ampu-
tations, cellulitis or abscesses of the foot, cellulitis or abscesses of the toe,
respectively. CONCLUSIONS: Administrative database analysis is an efficient tool
to track foot and toe serious complications, as only events requiring hospitalization
can be detected with this methodology.
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OBJECTIVES: To evaluate the most frequent outpatient care physiotherapy ser-
vices provided for trauma patients, based on age and regional distribution.
METHODS:Data were derived from the countrywide database of Hungarian Health
Insurance Administration (HHIA), based on official reports of outpatient care insti-
tutes. The 151 different types of treatment codes are listed in the chapter of the
Guidelines of HHIA for ‘Physiotherapists, massage-therapists, conductors and
other physiotherapy practices‘. Of the physiotherapeutic services provided for
trauma patients, the knee and lower leg injuries (ICD code S80-89) occurred with
the highest incidence. Data collected from the year 2008 were further analyzed
based on the distribution among the 7 different Hungarian regions and based on
age distribution, set to 5 years intervals. RESULTS: The total number of the pro-
vided 151 different types WHO-classified physiotherapy services was 29045736 in
the year of 2008; 3188650 of them with the ICD code group S00-S99 with the highest
incidence: 713898 of services for knee and lower leg injuries (S80–S89). The highest
number of physiotherapy treatment in total of 86048 cases was provided for pa-
tients in the age group 30 to 34, followed by age group of 35 to 39 with 77903 cases.
The average number of cases was 71.17/1000 persons. Injuries related treatments
occurred with the highest incidence in the Central-Hungarian region (81.07 cases/
1000 population) and with the lowest incidence in the Western-Transdanubian
region (62.52 cases/1000 population). CONCLUSIONS: In case of the traumatic in-
juries, the highest demand of the outpatient care physiotherapy services occurred
for knee and lower leg injured patients. The differences of the incidences (calcu-
lated per 1000 persons) in the regional distributions require further studies.
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HBA1C TESTING FREQUENCY IN PRIMARY CARE DIABETES PATIENTS IN
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OBJECTIVES: The HbA1c test is a lab test, which reveals average blood glucose over
a period of two to three months. Tight blood glucose control could reduce the risk
of diabetes related complications. Expert opinion recommends 6-monthly HbA1c
testing in stable and 3-monthly testing in type 1 and unstable type 2 diabetes
patients. Moreover, HbA1c should be measured more frequently for patinets whose
therapy is changing. The aim of this study was to measure the quality of diabetic
care as indicated by HbA1c testing frequency and to compare the frequency of
HbA1c testing in primary care diabetes patients in Germany (DE) and UK.
METHODS: Computerized data on lab values (IMS Disease Analyzer Multi-Country
Solution, 01/2011-12/2011) from general medicine practices throughout DE and UK
have been analysed and compared. This data warehouse includes the complete
diagnosis and therapy relevant information on diabetes patients in several coun-
tries. 159,031 T2D patients and 1,910 T1D patients from 1,001 GP practices in Ger-
many and 34,375 T2D patients and 1.506 T1D patients from 104 GP practices in UK
were included. RESULTS: 53.1% of T2D patients and 42.0% of T1D patients in Ger-
many, 87.0% of T2D patients and 69.1% of T1D patients in UK had at least one HbA1c
testing in the observation time. In Germany there were 1.5 HbA1c tests per year in
T2D patients and 1.1 tests per year in T1D patients. In UK T2D patients have in
average 3.1, T1D patients 2.0 HbA1c tests in 2011. CONCLUSIONS: The study re-
vealed that HbA1c testing was underused in both T1D and T2D patients. Improve-
ment is needed in the utilization of HbA1c testing among most diabetes patients in
Germany and UK. HbA1c tests should be obtained routinely in all persons with
diabetes, for the blood glucose control documentation and as part of continuing
care.
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OBJECTIVES: To examine physical function by muscle strength in the US elderly
population. METHODS: Individuals aged 50 and above from the National Health
and Nutrition Examination Survey (NHANES) 1999-2002databases were selected.
Physical function was measured via 20-foot walking speed [WS] in meters/second,
having difficulty walking up 10 steps (yes/no), and having difficulty standing up
from armless chairs (yes/no). Muscle strength was measured via the isokinetic
quadriceps strength in newtons. Two study cohorts were constructed based on age
and gender (10 groups) adjusted muscle strength (high strength  above the me-
dian within each age and gender group). Demographics, comorbidities, and body
mass index (BMI) were compared between the high and low strength groups. The
association between high/low muscle strength and 20-foot WS was analyzed via
multiple linear regression that utilized survey strata and weighting and controlled
for between-group differences in demographics, BMI, and comoribidites. Logistic
regressions were employed to examine the relationship between having difficulty
walking up 10 steps or standing up from armless chairs and high/low muscle
strength, respectively. RESULTS: The study included 646 individuals with 320 in
the high and 326 in the low strength cohorts. More individuals with low muscle
strength had diabetes, arthritis, and osteoporosis than those with high muscle
strength. Mean BMI was also higher in the high strength cohort. Controlling for
differences in demographics, comorbidities, and BMI, individuals in the high
strength cohort had significantly faster 20-foot WS speed (0.10, p0.05) and were
less likely to have difficulty standing up from armless chairs (Odds Ratio  0.32,
p0.05) compared with those in the low strength cohort. CONCLUSIONS: Among
individuals aged 50 and above in the US, high muscle strength is positively corre-
lated with WS but negatively correlated with having difficulty standing up from
armless chairs.
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OBJECTIVES: Emerging evidence suggests that cardiovascular risk factors like hy-
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pertension, serum cholesterol, and diabetes mellitus decreases the risk of Parkin-
son’s disease (PD). We therefore examined the epidemiologic association of PD
with hypertension, serum total cholesterol, and diabetes mellitus by conducting a
detailed meta-analysis of all studies published regarding this subject.METHODS:A
systematic comprehensive literature search was performed using PubMed,
EMBASE, and CINAHL (until March 2012) for observational cohort and case-control
studies using relevant keywords. Pooled relative risk (RR) was calculated using
random effects model. Pre specified subgroup analysis was performed to assess the
source of heterogeneity, according to study design, number of covariates adjusted
and adjusted for BMI and cardiovascular diseases. Subgroup and sensitivity anal-
ysis were also done. Heterogeneity and publication bias were also assessed.
RESULTS: 24 studies were included in the analysis. The pooled risk ratio of PD due
to hypertension (n8) was 0.78 (95% CI, 0.67-0.92, I271.85%), due to high serum
cholesterol (n7) was 0.95 (95% CI, 0.77-1.17, I2 75.86%), and due to diabetes
(n14) was 0.94 (95% CI, 0.76-1.16, I2 89.62%). Subgroup analysis showed a signif-
icant difference in effect estimate pooled by cohort and case-control studies (Pin-
teraction0.001). Pooled analysis of cohort studies for diabetes showed a pooled
risk ratio of 1.34 (95%CI, 1.12-1.60, I276.77%). We found no significant difference in
any subgroup analysis. CONCLUSIONS: We found evidence of significant inverse
associations of hypertension, hypercholesterolemia, and diabetes mellitus with
the risk of PD. Further well-designed investigations of the association of vascular
risk factors with the risk of PD are needed, particularly large-scale prospective
studies.
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GLYCAEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS (DM) IN SPAIN:
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OBJECTIVES: Technological developments allow remote monitoring of patients
and improve diabetes care. A mobile phone telemonitoring system (TM) might
improve the ability of DM patients to engage in treatment. The objective is to
estimate the annual costs that implementing a TM for glycaemic control in DM
patients might represent to the National Health System and to society in Spain.
METHODS: First, a systematic review of the literature was conducted to determine
cost drivers in DM TM. Electronic databases were searched to identify national and
international clinical and economic articles, published between January, 2001 and
December, 2011, reporting on the clinical benefits, health resources used and costs
associated to DM TM. Second, based on the data gathered, and adapted for Spain,
and on the assumption that TM favors treatment compliance, a mathematical
model was applied to determine the variation in costs associated to macro and
micro DM complications risk reduction derived from hypothetically reaching 100%
DM treatment compliance in groups of patients: compliant, noncompliant and
complications are undiagnosed. RESULTS: A total of 3.539 articles were identified;
48 were reviewed. TM decreases emergency visits (83%), disease related hospital
admissions (75%), length of hospital admission (51%), visits to the outpatient clinic
(40%) and to the specialist (19%). Reduction of indirect costs reaches 120.82 €per DM
patient/year due to less travel expenses (-6.30 €/visits) and productivity gain (-54
€/visits). Assuming that 100% of uncompliant DM patients become compliant (n 
1,550,634 patients) costs associated to macro- and micro-vascular complications
decreases by 5,500 € (€, 2011) million per year. Higher cost reductions are obtained
in the most prevalent vascular complications. CONCLUSIONS: These preliminary
results show that TM in DM patients reduces direct and indirect costs. Significant
costs reduction can be reached if DM treatment compliance is improved with TM in
Spain.
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CLINICAL AND ECONOMIC ANALYSIS OF “MOLICARE® PREMIUM EXTRA SOFT”
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Vorobiev P1, Krasnova L1, Shustov A1, Smola H2, Farafonova A3
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OBJECTIVES: To carry out a clinical-economic analysis of MoliCare® Premium ex-
tra soft diapers application efficiency for contact dermatitis* and pressure ulcers
prophylaxis with immobile urinary-incontinent patients.METHODS: Estimation of
typical management practice with immobile urinary-incontinent patients’ having
developed contact dermatitis* or pressure ulcers was performed by means of ex-
perts’ questioning. Only direct medical costs were taken into account in the re-
search. A comparative clinical-economic analysis was performed using Markov’s
model. A sensitivity analysis was performed taking into account retail and whole-
sale prices for absorbing means and skin care agents. RESULTS: Twenty weeks’
total costs calculated with Markov’s model use for contact dermatitis* and 1-4
degree pressure ulcers prophylaxis and treatment with one immobile urinary-
incontinent patient with absorbent means and skin care agents’ application were
5508 € in retail prices and 5276 € in wholesale prices; without their application the
costs were 7 446 €. Overall this Analysis shows that medical-prophylactic institu-
tions’ costs for contact dermatitis* and pressure ulcers’ prophylaxis and treatment
with one immobile urinary-incontinent patient without absorbing means and skin
care agents applying are considerably higher (by 41%) than when they are applied.
At the same time indirect costs including linen disinfection, washing, drying and
ironing were not taken into account and such costs can increase a costs’ total
figure. CONCLUSIONS:Absorbent means and skin care agents’ application for con-
tact dermatitis and pressure ulcers prophylaxis and treatment with immobile uri-
nary-incontinent patients is a dominant technique and cost efficacy of using ab-
sorbent means and skin care agents was demonstrated. The Branch standard
“Patients’ management protocol. Pressure ulcers” (2002) needs actualization taking
into account the data obtained in the present clinical-economic research.
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RECOMMENDATION FOR ROTAVIRUS VACCINATION AND HERD EFFECT:
ANALYZING COST DATA FROM A GERMAN STATUTORY HEALTH INSURANCE
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OBJECTIVES: To quantify the financial effects of the introduction of a recommen-
dation for rotavirus vaccination in Saxony, Germany, in 2008 using a retrospective
data analysis. Special emphasis is given to the herd effect.METHODS:We analyzed
the costs of rotavirus infection between 2007 and 2010 based on 360.000 observa-
tions from the AOK Plus of children under 5 years for Saxony. To investigate the
cost impact of the regional recommendation, we compared the associated costs of
the expected annual RVGE cases derived from 2005 when rotavirus vaccination was
not yet available, with the actual annual number of RVGE cases, vaccinations and
associated costs per age cohort. A decrease in RVGE cases in not vaccinated cohorts
was attributed to herd effect. We make distinction between in- and outpatient
cases, societal and SHI perspective as well as different age groups. RESULTS: Given
that the vaccination rate has increased from 5% to 61% in the observed period, we
obtained following estimates: the mean total cost reduction per year attributable to
introducing a recommendation for rotavirus vaccination is 4.5 million € (2.4 million
€) from the societal (SHI) perspective. The mean cost savings of vaccination per
avoided case rise from 572 € (291 €) in 2007 to 718 € (375 €) in 2010. The overall share
of outpatient costs is about 72% (60%). About 45% of the total savings is attributable
to herd effect. The herd effect per avoided case decreases over time while immu-
nity increases. CONCLUSIONS: A recommendation for rotavirus vaccination in
Saxony turns out to be cost saving from the SHI as well as the societal perspective.
This is mainly attributed to the herd effect being present when having high vacci-
nation rates.
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OBJECTIVES: To determine the relationship of polypharmacy on blood pressure
(BP) control, compliance, persistence, the cost and incidence of cardiovascular
events (CVD) in patients with moderate/severe hypertension. METHODS: An ob-
servational multicenter retrospective study. We evaluated patients 30 years who
started a third antihypertensive treatment during 2004-2006. Depending on the
number of chronic medications, we established 3 groups: regular consumption of
3-6 drugs, between 7-10 and 11. Top measures: sociodemographic, comorbidity,
BP, compliance and persistence. For each group we determined the incidence of
new CVD and total costs. Patients were followed for 4 years. RESULTS: We evalu-
ated 1,906 patients, 765 between 3-6 drugs, 624 between 7-10 and 517 in _ 11 (P 
0.001). Overage age: 69.4 years and 55.5% women. The group of 3-6 drugs showed
better BP control (51.8 vs. 47.0 and 41.1%, P  0.001), compliance (71.4 vs. 69.9 and
67.1%, P 0.017), persistence (50.1 vs. 45.5 and 46.2%, P 0.044) and lower incidence
of CVD (12.2 vs. 19.7 and 30.2%, P 0.001), respectively. The average/unit total cost
was 3,369.1 vs. 4,362.1 and s 4,902.3 (P 0.001). The presence of CVD was associated
with therapy non-compliance (odds ratio [OR] 1.9, 95% confidence interval [95% CI]
1.1 to 3.6) and lower BP control (OR 1.4 [95% CI 1.1-2.0], P  0.05). The use of anti-
hypertensive fixed dose has greater compliance (72.8 vs. 68.2%), persistence (64.4
vs. 39.3%) and degree of BP control (52.6 vs. 43, 8%), P  0.001. CONCLUSIONS:
Polypharmacy is associated with lower compliance and persistence to antihyper-
tensive treatment, cardiovascular disease and increased health care costs.
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OBJECTIVES:We estimated the impact of influenza A(H1N1)2009 infection in terms
of patient’s health care services utilization, work absenteeism and costs, both dur-
ing the pandemic (2009-10) and postpandemic-seasonal (2010-11) waves in Spain.
METHODS: Longitudinal, multi-centre study of in- and outpatients with RT-PCR
confirmed diagnosis of influenza at pandemic(PAND) and postpandemic-season-
al(POST) waves. Health care and social resources utilization were the main vari-
ables, together with clinical and sociodemographic characteristics. Evaluations
were conducted at hospital-admission or ambulatory index-visit, and after recov-
ery (median100 days). Unitary costs and Monte Carlo simulation were applied to
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